Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Scientists discover stem cells in amniotic fluid
Researchers at the Wake Forest University School of Medicine discovered a small number of stem cells in amniotic fluid – estimated at 1% – that can give rise
Researchers at the Wake Forest University School of Medicine discovered a small number of stem cells in amniotic fluid – estimated at 1% – that can give rise
Scientists from the University of Melbourne and Australian National University studied 6,560 people living in Canberra or neighboring Queanbeyan. The study confirmed that carriers of the APOE4 gene
Under the terms of the agreement, OSI could receive up to $360 million in potential and other payments, plus royalties on sales of any compounds successfully commercialized from
In the study HY10275 demonstrated statistically significant improvements in Wake After Sleep Onset (WASO) in both 1mg and 3mg doses studied. WASO decreased in a dose dependent manner
This study is the second company-sponsored phase II trial and part of a broader program to evaluate the role of 6R-BH4 in the treatment of different types of
This license agreement allows Biotecnol to use the PER.C6 human cell line for preclinical and phase I development of its antibody products, which are composed of tribodies and
The drug targets the HER-2 receptor positive type of breast cancer, where HER-2 receptors are overexpressed, the drug attempts to reduce the number of overexpressions. Of all breast
“The signing of this agreement builds upon previous manufacturing work through which fundamental cGMP processing parameters for L-DOS47 have been developed,” said John Docherty, Helix’s vice president of
Pertuzumab or 2C4 is the first in a new class of investigational agents known as HER dimerization inhibitors (HDIs). Pertuzumab is designed to bind to the HER2 receptor
These agreements follow a master settlement Lilly entered into in June 2005 that covered approximately 8,000 claimants in the US, as well as additional settlements of approximately 2,500